Lung Small Cell Carcinoma, A Subtype

specific

A molecular subtype of lung small cell carcinoma characterized by the overexpression of neurogenic differentiation factor 1 (NEUROD1). It is associated with low expression of neuroendocrine markers and variant morphology.

15

Centers

15

Active Trials

—

Cancer Funding

Top Centers for Lung Small Cell Carcinoma, A Subtype(15)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
The University of Texas MD Anderson Cancer CenterHouston, TX
NCI Comprehensive
Active Research Program
53.3
2
The University of Chicago Medicine Comprehensive Cancer CenterChicago, IL
NCI Comprehensive
Active Research Program
53.3
3
University of Colorado Cancer CenterAurora, CO
NCI Comprehensive
Active Research Program
53.3
4
Roswell Park Comprehensive Cancer CenterBuffalo, NY
NCI Comprehensive
Active Research Program
53.3
5
University of Virginia Cancer CenterCharlottesville, VA
NCI Comprehensive
Active Research Program
53.3
6
Sylvester Comprehensive Cancer CenterMiami, FL
NCI Clinical
Active Research Program
53.3
7
VCU Massey Comprehensive Cancer CenterRichmond, VA
NCI Comprehensive
Active Research Program
53.3
8
Wilmot Cancer Institute, UR MedicineRochester, NY
NCI Clinical
Active Research Program
53.3
9
The University of Kansas Cancer CenterKansas City, KS
NCI Comprehensive
Active Research Program
53.3
10
University of Illinois Cancer CenterChicago, IL
Active Research Program
53.3
11
Boston University Cancer CenterBoston, MA
Active Research Program
53.3
12
Houston Methodist Dr. Mary and Ron Neal Cancer CenterHouston, TX
Active Research Program
53.3
13
Cancer Center at IllinoisUrbana, IL
Active Research Program
53.3
14
Stony Brook Cancer CenterStony Brook, NY
Active Research Program
53.3
15
Loma Linda University Cancer CenterLoma Linda, CA
Active Research Program
53.3

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →